Kaleido Biosciences, Inc. (KLDO) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Kaleido Biosciences, Inc. (KLDO).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $0.0₃1

Daily Change: $0.00 / 0.00%

Range: $0 - $0

Market Cap: $4,262

Volume: 0

Performance Metrics

1 Week: -50.00%

1 Month: -95.00%

3 Months: %

6 Months: %

1 Year: 9,900%

YTD: 9,900%

Details

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Selected stocks

Yuka Group Inc. (YUKA)

World Copper Ltd. (WCUFF)

Wienerberger Baustoffindustrie AG (WBRBY)